Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of an Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancers

NCT01065441 is registered in ClinicalTrials.gov with Michael Har-Noy as lead sponsor.

NCT NCT01065441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01065441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of an Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancers
Lead sponsor
Michael Har-Noy
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2010
Completion date
July 31, 2013
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, melanoma, non-small cell lung cancer, ovarian cancer, prostate cancer, sarcoma, solid tumors stage ii, stage iii and stage iv